Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin

BACKGROUND: Recombinant human erythropoietin (rhEPO) is considered to be one of the most pivotal pharmaceutical drugs in the market because of its clinical application in the treatment of anemia-associated disorders worldwide. However, like other therapeutic proteins, it does not have suitable pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohan, Reza Ahangari, Madadkar-Sobhani, Armin, Khanahmad, Hossein, Roohvand, Farzin, Aghasadeghi, Mohammad Reza, Hedayati, Mohammad Hossein, Barghi, Zahra, Ardestani, Mehdi Shafiee, Inanlou, Davoud Nouri, Norouzian, Dariush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131188/
https://www.ncbi.nlm.nih.gov/pubmed/21753873
http://dx.doi.org/10.2147/IJN.S19081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131188/
https://www.ncbi.nlm.nih.gov/pubmed/21753873
http://dx.doi.org/10.2147/IJN.S19081

Ejemplares similares